Subscribe

Fidelity, Jerry Schlichter trade barbs over Abigail Johnson testimony in 401(k) lawsuit

Mr. Schlichter, who represents plaintiffs in the suit against MIT, is seeking to have Ms. Johnson testify about a quid-pro-quo allegation.

Fidelity Investments and plaintiff’s attorney Jerome Schlichter are engaged in a war of words over the potential for Fidelity chairman and CEO Abigail Johnson to appear and testify at an upcoming trial around 401(k) mismanagement.

The lawsuit in question, Tracey et al v. Massachusetts Institute of Technology, hinges on whether the university breached its fiduciary duty by retaining Fidelity as its 401(k) plan record keeper and using high-cost, underperforming investments.

Neither Fidelity nor Ms. Johnson are defendants in the lawsuit. But plaintiffs claim Ms. Johnson has direct knowledge of a quid-pro-quo arrangement between MIT and Fidelity that would help prove MIT’s malfeasance.

Mr. Schlichter, who represents the plaintiffs, included Ms. Johnson on a preliminary list of witnesses at the trial, which is scheduled to begin in September — an outcome Fidelity is sorely trying to avoid.

The company, which is the largest record keeper of defined-contribution plans, with more than $2 trillion in assets, labeled plaintiffs’ efforts to obtain Ms. Johnson’s testimony a “transparent attempt to harass Ms. Johnson and to attract media attention,” according to a court filing requesting a protective order against a subpoena.

[Recommended video: Retirement advisers can boost business by focusing on participants in these ways]

Ms. Johnson has “no “relevant testimony” and “lacks any knowledge” of the relevant facts, according to the filing made Aug. 19 in Massachusetts federal court.

Plaintiffs argue that Ms. Johnson’s claims of harassment and media attention are “illogical,” since the preliminary list of witnesses was only shared with defendants, according to a filing Aug. 26 asking the Massachusetts court to deny Fidelity’s “premature” motion.

In addition, Ms. Johnson “offers no evidence to meet her burden of demonstrating that she lacks unique knowledge,” the plaintiffs’ filing said.

Plaintiffs broached the quid-pro-quo allegations in an Aug. 5 court filing, claiming that MIT retained Fidelity’s record-keeping services and in-house investment funds for its 401(k) plan with the expectation that Fidelity and Ms. Johnson would make a large donation to the university.

Mr. Schlichter said he had unearthed new evidence, such as emails from MIT management, proving the existence of this mutually beneficial arrangement, and attempted to bring a new fiduciary-breach claim against MIT.

Plaintiffs made “reckless statements” about Ms. Johnson and Fidelity in a press release announcing this new evidence, according to defense attorneys.

Judge Nathaniel M. Gorton denied Mr. Schlichter’s motion to bring the new claim, arguing in an Aug. 8 order that asserting a new legal theory right before trial was “fundamentally unfair.”

Mr. Schlichter said the press release was “in no way ‘reckless’ or ‘false.’”

The lawsuit is one of several Mr. Schlichter has filed against more than a dozen prominent universities since 2016 alleging retirement-plan mismanagement.

Related Topics:

Learn more about reprints and licensing for this article.

Recent Articles by Author

SEC issues FAQs on investment advice rule

The agency published answers to four questions about Form CRS.

SEC proposes tougher sales rule for exchange-traded products

The agency, concerned about consumer protection, says clients need a baseline understanding of product risk

Pete Buttigieg proposes a ‘public’ 401(k) program

The proposal is similar to others seeking to improve access to workplace retirement plans but would require an employer match.

DOL digital 401(k) rule not digital enough, industry says

Some stakeholders say the disclosure proposal is still paper-centric and should take into account newer technologies.

Five brokers lose Ohio National lawsuit over annuity commissions

Judge rules the brokers weren't beneficiaries of the selling agreement between the insurer and broker-dealers.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print